Restatement of Previously Issued Financial Statements - Schedule of Restatement of Previously Issued Financial Statements - Condensed Consolidated Cash Flows (Detail) - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2024	Mar. 31, 2023
Cash flows from operating activities:
Net income		$ 3,296	$ 15,337
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		16,909	15,370
Amortization of debt discount and issuance costs		3,809	457
Stock-based compensation		8,776	7,254
Deferred income taxes, net		(1,122)	(787)
Contingent consideration		0	1,235
Operating lease right of use asset amortization	[1]	4,394	3,349
Other		32	(719)
Changes in operating assets and liabilities, excluding impact of acquisitions:
Accounts receivable		6,653	(16,832)
Inventories		3,167	(5,845)
Prepaid expenses and other assets		(2,338)	(5,680)
Other assets		320	(434)
Accounts payable		(645)	(1,194)
Accrued expenses		2,980	(2,299)
Operating lease Liabilities		(1,375)	(2,870)
Long-term liabilities		(148)	4,812
Total cash provided by operating activities		44,708	11,154
Cash flows from investing activities:
Additions to capitalized software costs		(27)	(924)
Purchases of property, plant and equipment		(8,346)	(8,509)
Other investing activities		11	0
Total cash used in investing activities		(8,362)	(9,433)
Cash flows from financing activities:
Proceeds from exercise of stock options		945	29
Payment of tax withholding obligation on vesting of restricted stock		(7,622)	(9,592)
Payment of earnout consideration		(2,160)	0
Other financing activities		(137)	0
Total cash used in financing activities		(8,974)	(9,563)
Effect of exchange rate changes on cash and cash equivalents		1,922	993
Net increase (decrease) in cash and cash equivalents		29,294	(6,849)
Cash, cash equivalents and restricted cash, beginning of period		751,323	523,458
Cash and cash equivalents, end of period		780,617	516,609
Supplemental disclosure of non-cash investing and financing activities:
Assets acquired under operating leases		23,093	179
Fair value of shares of common stock issued for contingent consideration earnouts		541	$ 0
As Previously Reported
Cash flows from operating activities:
Net income		2,094
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		16,791
Amortization of debt discount and issuance costs		3,809
Stock-based compensation		8,776
Deferred income taxes, net		(833)
Contingent consideration		0
Operating lease right of use asset amortization		(19,465)
Other		(105)
Changes in operating assets and liabilities, excluding impact of acquisitions:
Accounts receivable		6,653
Inventories		3,167
Prepaid expenses and other assets		(4,571)
Other assets		320
Accounts payable		(645)
Accrued expenses		6,381
Operating lease Liabilities		22,484
Long-term liabilities		(148)
Total cash provided by operating activities		44,708
Cash flows from investing activities:
Additions to capitalized software costs		(27)
Purchases of property, plant and equipment		(8,346)
Other investing activities		11
Total cash used in investing activities		(8,362)
Cash flows from financing activities:
Proceeds from exercise of stock options		945
Payment of tax withholding obligation on vesting of restricted stock		(7,622)
Payment of earnout consideration		(2,160)
Other financing activities		(137)
Total cash used in financing activities		(8,974)
Effect of exchange rate changes on cash and cash equivalents		1,922
Net increase (decrease) in cash and cash equivalents		29,294
Cash, cash equivalents and restricted cash, beginning of period		751,323
Cash and cash equivalents, end of period		780,617
Supplemental disclosure of non-cash investing and financing activities:
Assets acquired under operating leases		23,093
Fair value of shares of common stock issued for contingent consideration earnouts		541
Revenue Adjustments
Cash flows from operating activities:
Net income		1,398
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		0
Amortization of debt discount and issuance costs		0
Stock-based compensation		0
Deferred income taxes, net		(230)
Contingent consideration		0
Operating lease right of use asset amortization		0
Other		0
Changes in operating assets and liabilities, excluding impact of acquisitions:
Accounts receivable		0
Inventories		0
Prepaid expenses and other assets		2,233
Other assets		0
Accounts payable		0
Accrued expenses		(3,401)
Operating lease Liabilities		0
Long-term liabilities		0
Total cash provided by operating activities		0
Cash flows from investing activities:
Additions to capitalized software costs		0
Purchases of property, plant and equipment		0
Other investing activities		0
Total cash used in investing activities		0
Cash flows from financing activities:
Proceeds from exercise of stock options		0
Payment of tax withholding obligation on vesting of restricted stock		0
Payment of earnout consideration		0
Other financing activities		0
Total cash used in financing activities		0
Effect of exchange rate changes on cash and cash equivalents		0
Net increase (decrease) in cash and cash equivalents		0
Cash, cash equivalents and restricted cash, beginning of period		0
Cash and cash equivalents, end of period		0
Supplemental disclosure of non-cash investing and financing activities:
Assets acquired under operating leases		0
Fair value of shares of common stock issued for contingent consideration earnouts		0
Other Adjustments
Cash flows from operating activities:
Net income		(196)
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		118
Amortization of debt discount and issuance costs		0
Stock-based compensation		0
Deferred income taxes, net		(59)
Contingent consideration		0
Operating lease right of use asset amortization		23,859
Other		137
Changes in operating assets and liabilities, excluding impact of acquisitions:
Accounts receivable		0
Inventories		0
Prepaid expenses and other assets		0
Other assets		0
Accounts payable		0
Accrued expenses		0
Operating lease Liabilities		(23,859)
Long-term liabilities		0
Total cash provided by operating activities		0
Cash flows from investing activities:
Additions to capitalized software costs		0
Purchases of property, plant and equipment		0
Other investing activities		0
Total cash used in investing activities		0
Cash flows from financing activities:
Proceeds from exercise of stock options		0
Payment of tax withholding obligation on vesting of restricted stock		0
Payment of earnout consideration		0
Other financing activities		0
Total cash used in financing activities		0
Effect of exchange rate changes on cash and cash equivalents		0
Net increase (decrease) in cash and cash equivalents		0
Cash, cash equivalents and restricted cash, beginning of period		0
Cash and cash equivalents, end of period		0
Supplemental disclosure of non-cash investing and financing activities:
Assets acquired under operating leases		0
Fair value of shares of common stock issued for contingent consideration earnouts		$ 0

[1] *Amounts reclassified in the current presentation from a component of “Changes in operating assets and liabilities” to a component of “Adjustments to reconcile net income.” The reclassification did not result in any change to total cash provided by operating activities.